Literature DB >> 29523677

Treatment Choices for Hepatitis C in Patients with Kidney Disease.

Fabrizio Fabrizi1, Piergiorgio Messa2,3.   

Abstract

Entities:  

Keywords:  Developed Countries; Fluid Therapy; Hepacivirus; Hepatitis C; Humans; Kidney Diseases; Patient Selection; Prevalence; kidney disease; renal dialysis; therapy

Mesh：

Substances：

Year:  2018        PMID： 29523677      PMCID： PMC5969487          DOI： 10.2215/CJN.12621117

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

Authors:  David S Goldberg; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Matthew Levine; K Rajender Reddy; Roy D Bloom; Susanna M Nazarian; Deirdre Sawinski; Paige Porrett; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Midhat Farooqi; Caren Gentile; Jennifer Smith; Peter P Reese
Journal:  N Engl J Med       Date:  2017-04-30       Impact factor: 91.245

2.  Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.

Authors:  Varun Saxena; Farrukh M Koraishy; Meghan E Sise; Joseph K Lim; Monica Schmidt; Raymond T Chung; Annmarie Liapakis; David R Nelson; Michael W Fried; Norah A Terrault
Journal:  Liver Int       Date:  2016-03-24       Impact factor: 5.828

Review 3.  Hepatitis C virus and atherosclerosis: A legacy after virologic cure?

Authors:  M F Bassendine; S U Nielsen; S H Bridge; D J Felmlee; D A Sheridan; C J Packard; R D Neely
Journal:  Clin Res Hepatol Gastroenterol       Date:  2016-11-11       Impact factor: 2.947

4.  Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.

Authors:  David A Goodkin; Brian Bieber; Michel Jadoul; Paul Martin; Eiichiro Kanda; Ronald L Pisoni
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-01       Impact factor: 8.237

Review 5.  Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Fabrizi; Simona Verdesca; Piergiorgio Messa; Paul Martin
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

Review 6.  Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.

Authors:  Tao Li; Yundong Qu; Ying Guo; Yan Wang; Lei Wang
Journal:  Liver Int       Date:  2017-01-02       Impact factor: 5.828

7.  Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Authors:  Paul J Pockros; K Rajender Reddy; Parvez S Mantry; Eric Cohen; Michael Bennett; Mark S Sulkowski; David E Bernstein; Daniel E Cohen; Nancy S Shulman; Deli Wang; Amit Khatri; Manal Abunimeh; Thomas Podsadecki; Eric Lawitz
Journal:  Gastroenterology       Date:  2016-03-11       Impact factor: 22.682

Review 8.  Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?

Authors:  F Fabrizi; V Dixit; P Messa
Journal:  J Viral Hepat       Date:  2012-07-17       Impact factor: 3.728

9.  Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

Authors:  Edward Gane; Eric Lawitz; David Pugatch; Georgios Papatheodoridis; Norbert Bräu; Ashley Brown; Stanislas Pol; Vincent Leroy; Marcello Persico; Christophe Moreno; Massimo Colombo; Eric M Yoshida; David R Nelson; Christine Collins; Yang Lei; Matthew Kosloski; Federico J Mensa
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

10.  Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Authors:  David Roth; David R Nelson; Annette Bruchfeld; AnnMarie Liapakis; Marcelo Silva; Howard Monsour; Paul Martin; Stanislas Pol; Maria-Carlota Londoño; Tarek Hassanein; Philippe J Zamor; Eli Zuckerman; Shuyan Wan; Beth Jackson; Bach-Yen Nguyen; Michael Robertson; Eliav Barr; Janice Wahl; Wayne Greaves
Journal:  Lancet       Date:  2015-10-05       Impact factor: 202.731
  10 in total
  2 in total

Review 1.  Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.

Authors:  Natasha Silva Constancio; Maria Lucia Gomes Ferraz; Carmen Tzanno Branco Martins; Angiolina Campos Kraychete; Paulo Lisboa Bitencourt; Marcelo Mazza do Nascimento
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

2.  Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study.

Authors:  Carmen González-Corvillo; Isabel Beneyto; Ana Sánchez-Fructuoso; Manel Perelló; Angel Alonso; Auxiliadora Mazuecos; Carlos Jiménez; Sofía Zárraga; Javier Paul; Ricardo Lauzurica; Domingo Hernández; Luis Guirado; Antonio Franco; Juan Carlos Ruiz; Santiago Llorente; Marta Crespo; Alberto Rodríguez-Benot; María Del Carmen de Gracia Guindo; Carmen Díaz-Corte; Miguel Ángel Gentil
Journal:  Transplant Direct       Date:  2019-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.